Geography
European VC Funds
Venture capital funds investing across Europe. Browse European VCs, their focus areas, check sizes, and investment stages.
Beringea is a transatlantic venture capital firm with a significant presence in the UK and the US, managing over $900 million in assets. Founded in 1988, Beringea has made a name for itself by investing in high-growth companies across sectors such as healthcare, clean technology, media, consumer services, SaaS, and technology. Notable investments from Beringea include successful exits like D3O, ContactEngine, and Inskin Media, showcasing their ability to nurture and grow impactful businesses. Their portfolio also features promising companies like MPB, Flywheel, Asterra, Moonshot, and Akadeum, which highlight their focus on innovation and scalability. Beringea’s investment strategy involves early and growth-stage funding, with typical investments ranging from $2 million to $10 million. They emphasize scalable business models targeting large markets and have a strong track record of leading funding rounds and providing significant operational support to their portfolio companies. Geographically, Beringea operates out of Farmington Hills, Michigan, and London, with additional offices and operations supporting their global reach. The firm's team includes experienced partners like Michael Gross and Stuart Veale, who bring extensive industry knowledge and leadership to the table.
Berkeley SkyDeck is UC Berkeley's premier startup accelerator, integrating the extensive resources of one of the world's top universities with a robust venture fund. Launched as a partnership between the Haas School of Business, the College of Engineering, and the Office of the Vice Chancellor for Research, SkyDeck combines traditional accelerator consulting with academic expertise and research resources. The Berkeley SkyDeck Fund, with $85 million under management, invests in startups participating in the accelerator program and those with Berkeley affiliations. Each startup in the accelerator receives an initial investment of $200,000. The fund is known for its high activity, making over 100 investments in just three years, backed by prominent VCs like Sequoia Capital and Mayfield Fund. SkyDeck provides startups with access to a vast network of advisors, industry partners, and UC Berkeley alumni, helping them with sales, hiring, and further financing introductions. This network-driven approach has proven successful for alumni startups like DeepScribe and SuperAnnotate, which have raised significant funds and achieved substantial growth. The accelerator supports a diverse range of startups from various sectors and stages, including biotech, hardware, consumer products, and enterprise solutions. SkyDeck also emphasizes diversity, equity, and inclusion, actively working to support underrepresented founders.
Bessemer Venture Partners (BVP), headquartered in San Francisco, is one of the oldest venture capital firms in the United States. Established in 1911, BVP has a long history of investing in early- and growth-stage companies across various industries, including technology, healthcare, and consumer sectors. Some of their notable investments include Shopify, LinkedIn, DocuSign, Pinterest, and Yelp. BVP is known for its systematic approach to venture capital, leveraging deep industry insights and a decentralized decision-making process. This allows individual partners significant autonomy to invest across different stages, industries, and geographies. The firm has offices not only in the U.S. but also in India, Israel, and the UK. BVP has raised multiple funds over the years, including a $3.85 billion early-stage fund in 2021 and a $780 million buyout fund under BVP Forge in 2022. These funds reflect their strategy of supporting startups from inception through to growth and eventual exit . Their "Anti-Portfolio" is a unique feature on their website, showcasing major investment opportunities they missed, including companies like Apple and eBay, highlighting their commitment to transparency and learning from past decisions . With a focus on fostering innovation and supporting dynamic founders, Bessemer Venture Partners continues to be a significant player in the global venture capital landscape.
Bethnal Green Ventures (BGV), founded in 2012 and based in London, is Europe's leading early-stage tech for good venture capital firm. BGV invests in ambitious teams using technology to tackle pressing social and environmental challenges. They have backed 177 ventures so far, with notable companies like Chatterbox, LettUs Grow, and Bright Little Labs in their portfolio. These investments have collectively impacted the lives of 17 million people and generated £80 million in sales of tech for good products and services in 2022. BGV's investment strategy focuses on sectors such as HealthTech, Sustainability Tech, and Enterprise Applications, with most of their investments being in the United Kingdom. They provide initial funding of £60,000 for a 7% equity stake through their Tech for Good programme, which includes six weeks of workshops and bespoke coaching. They also offer follow-on funding from pre-seed to Series A for the most promising ventures. BGV has a strong commitment to diversity, aiming for at least half of their investments to be in ventures founded by women. They are also the first UK VC to certify as a B Corp, reflecting their dedication to transparency and ethical practices.
Better Tomorrow Ventures (BTV) is a San Francisco-based venture capital firm focused on pre-seed and seed-stage investments in fintech companies globally. Founded by Jake Gibson and Sheel Mohnot, BTV leverages their extensive experience and networks in the fintech industry to support startups with ideation, key hires, customer introductions, and fundraising. They lead rounds with check sizes ranging from $500k to $3 million and manage $225 million in assets under management (AUM). BTV has invested in over 100 fintech companies, collaborating with top-tier VCs. Their portfolio includes notable companies like Albert, Lattice, Mercury, Ironclad, Flexport, and Ramp. They emphasize being hands-on partners, offering not just capital but also strategic guidance and operational support to help founders build successful companies. The team at BTV includes experienced operators who have built and exited startups themselves, bringing deep industry knowledge and a passion for fintech. This commitment to early-stage fintech innovation makes BTV a prominent player in the venture capital landscape.
Beyond Black, now known as Extantia Capital, is a Berlin-based venture capital firm focused on breakthrough climate technology that significantly reduces carbon emissions. With investments in companies like BeZero Carbon and Betteries, the fund has a clear focus on sectors like environmental services and energy. Extantia is particularly active in the cleantech space, seeking innovations that target decarbonization and other critical environmental challenges. Geographically, the fund predominantly invests in European startups, with an average check size of around $3 million. While they typically make about two investments per year, they prefer to lead rounds and get deeply involved with their portfolio companies. Their strategy prioritizes businesses that align with ESG (Environmental, Social, and Governance) principles, emphasizing sustainable solutions with long-term impacts. Founded by a team including Sebastian Heitmann and Yair Reem, Extantia brings together a group of seasoned investors committed to climate tech innovation. Startups looking to engage with Extantia should focus on how their solutions contribute to climate resilience and carbon reduction, as the firm builds its funnel around high-impact technologies and ventures.
Big Idea Ventures, founded in 2018, is a leading venture capital firm focusing on the alternative protein and food technology sectors. With over 110 early-stage investments, they have become the most active investor in FoodTech globally. The firm operates through its New Protein Fund and Generation Food Rural Partners fund, supporting innovative companies in plant-based, cell-based, and fermentation-enabled food technologies. Notable investments include companies like Naturannova, which creates sustainable peptide-based flavors using AI, and SoundEats, a cultivated seafood pioneer. Other standout portfolio companies are New Wave Biotech, which develops bioprocess optimization software, and Loki Foods, which produces plant-based seafood using renewable energy in Iceland. Big Idea Ventures runs bi-annual accelerator programs in New York, Paris, and Singapore, providing selected companies with a $200,000 investment and access to an extensive network of partners and investors. This hands-on support helps startups navigate product development, scaling, and market entry. Led by founder Andrew D. Ive, Big Idea Ventures collaborates with strategic partners like Temasek Holdings, Tyson Ventures, and Givaudan, aiming to drive significant advancements in food security and sustainability.
Big Pi Ventures is a venture capital firm based in Greece, focusing on seed and early-stage investments, particularly in deep-tech and science-driven startups. Established with a vision to drive transformative innovation, Big Pi partners with exceptional teams developing technologies that address significant global challenges. Their investments span various sectors, including artificial intelligence, health and life sciences, and climate technology, often targeting companies with strong intellectual property or technological advantages. The firm is anchored in Greece but maintains a global perspective, requiring that its portfolio companies establish substantial operations in Greece. Notable investments include companies like TileDB, Orfium, and Navenio, reflecting their commitment to backing ventures that have the potential to scale internationally. Big Pi is led by a team of seasoned entrepreneurs and investors, including Marco Veremis, co-founder of Upstream, and Alex Eleftheriadis, a pioneer in video compression technology. The team offers more than just capital, providing strategic support in areas like product design, scaling, and global market expansion. Their latest rebranding and new fund, announced in 2023, signify their ongoing commitment to fostering innovation and supporting the next generation of tech leaders.
BioGeneration Ventures (BGV) is a prominent venture capital firm based in Naarden, Netherlands, specializing in early-stage European biotech companies. With over €400 million under management, BGV focuses on sectors like biopharma, medtech, and diagnostics. Their portfolio features notable investments in companies such as AcertaPharma, argenx, and New Amsterdam Pharma, underscoring their success in advancing groundbreaking scientific innovations and addressing unmet medical needs. BGV typically engages in seed to early growth stages, strategically guiding companies through clinical trials and drug development to achieve substantial exits. Their rigorous selection process ensures they back ventures with the highest potential for impactful outcomes. BGV's investment philosophy centers on combining deep scientific expertise with commercial insight to build world-class biotech firms. The firm is led by a team of experienced professionals, including managing partners Edward van Wezel and Suzanne Morsink, who bring extensive backgrounds in life sciences and venture capital. They actively support portfolio companies with strategic guidance, leveraging their broad network and industry knowledge to drive growth and innovation. BGV is committed to fostering the next generation of biotech leaders, with a clear focus on creating value for both investors and society by addressing critical health challenges through cutting-edge science and technology
BioMedPartners, through its BioMedInvest funds, focuses on venture capital investments in early to mid-stage companies in the biotechnology, pharmaceutical, and medical technology sectors. Based in Basel, Switzerland, the firm supports innovations primarily in the Alpine region and other European markets. Notable portfolio companies include Aleva Neurotherapeutics, developing next-generation implants for deep brain stimulation; Anergis, which focuses on peptide-based immunotherapies for allergies; and Evolva, a biotech firm creating sustainable ingredients for health and nutrition. Additionally, BioMedPartners has invested in companies like Hookipa Biotech, which develops novel immunotherapies for infectious diseases and cancer, and Sequana Medical, specializing in implantable fluid management systems. The BioMedPartners team is led by General Partners such as Dr. Markus Hosang and Dr. Michael Wacker, who bring extensive experience in drug development, finance, and technology. The firm takes an active role in the development of its portfolio companies, often leading investment rounds and participating as a syndicate partner.
Bioqube Ventures is a specialist life sciences venture capital firm focused on early-stage investments in Europe, particularly in therapeutic assets and disruptive healthcare technologies. Founded in 2016 by Debora Dumont and Nico Vandervelpen, the firm launched its independent fund, Bioqube Factory Fund I, in 2020. This fund, which has secured over €60 million in its initial closing, aims to support the development of breakthrough therapies by leveraging Bioqube's unique dual investment model. This model includes both traditional venture investments and a "Create" strategy, which focuses on de-risking projects before establishing new ventures. The fund's strategy is deeply rooted in supporting high-potential scientific innovations, transforming them into commercially viable biotechnologies. Bioqube has strong partnerships with prominent investors like the European Investment Fund, Johnson & Johnson Innovation, and Genmab, further bolstering its ability to drive significant advancements in the life sciences sector. The Bioqube team is composed of experienced fund managers, sector experts, and serial entrepreneurs, bringing a hands-on approach to guiding portfolio companies through their growth stages. The firm has a significant presence in Europe, with a focus on regions such as the Benelux, France, and Germany, aiming to build a new generation of leading biotech companies.
Bitkraft Ventures is a leading venture capital firm focused on gaming, esports, and interactive media. Founded in 2015 by Jens Hilgers, Bitkraft has established itself as a pioneer in the gaming and Web3 investment space. The firm invests globally, targeting early-stage companies from Seed to Series B rounds. Bitkraft's portfolio includes over 135 companies spanning six continents, with notable investments in startups like Flock Freight, FitXR, and Honeybee Health. The firm's latest fund, Bitkraft Venture Fund 3, has raised $275 million to continue supporting innovative gaming and interactive media companies. Bitkraft's investment strategy emphasizes the convergence of physical and digital worlds, a concept they refer to as "Synthetic Reality." This vision encompasses advancements in AI, VR/AR, and blockchain technologies, aiming to create immersive and interconnected experiences. The team at Bitkraft is comprised of experienced entrepreneurs and industry leaders, providing both capital and strategic guidance to their portfolio companies. With a global presence and deep industry connections, Bitkraft Ventures remains at the forefront of driving innovation in gaming and interactive media.
Bits x Bites is a Shanghai-based venture capital firm and China’s first dedicated agrifood tech investor. Founded in 2016 by Matilda Ho, the firm focuses on early-stage startups tackling the most critical challenges in the food system, including food security, safety, and sustainability. Their investments span the entire food supply chain, from farm innovations to novel food production technologies, helping to revolutionize agriculture in China and beyond. Bits x Bites manages over $100 million across its funds, with a strong emphasis on scalable technologies that can make a measurable impact on food production and environmental sustainability. Their portfolio includes companies like EAVision, which specializes in autonomous drones for complex farming terrains, and Mojia Bio, a biomanufacturing startup that produces eco-friendly nutrients for the food industry. These investments reflect the firm’s commitment to advancing solutions in precision agriculture, alternative proteins, and biomanufacturing. With a global outlook, Bits x Bites evaluates around 1,200 startups annually, targeting companies with technologies that can be applied in China. They support their portfolio companies through partnerships with industry leaders such as Syngenta and Temasek, offering access to valuable resources and markets. The firm’s multidisciplinary team of experts provides hands-on guidance to help startups scale and commercialize their innovations in the Chinese market, shaping the future of food technology in the region.
Black Pearls VC is an early-stage venture capital firm based in Gdańsk, Poland, with a strategic focus on the Baltic Sea Region and Central Europe. They are particularly keen on deep tech startups developing unique, scalable technologies. The fund supports businesses from seed to Series A stages, with initial investments ranging from €100k to €1m and follow-on investments up to €3m. The firm has a sector-agnostic approach but has made significant strides in digital health, enterprise software, fintech, and deep tech. Notable portfolio companies include Nanoxo, a developer of non-toxic quantum dots for various industries; Xopero, specializing in data protection solutions; and Prosoma, which offers digital therapeutics for cancer patients. Black Pearls VC's investment strategy emphasizes collaboration, often co-investing with other prominent funds. They focus on backing entrepreneurs with groundbreaking ideas and providing extensive support through their global network of advisors and partners. The team includes experts like Managing Partner Marcin P. Kowalik, who brings a wealth of experience in corporate finance and investment management. For startups looking to attract Black Pearls VC, it is essential to highlight the scalability and uniqueness of their technology. Approaching them through detailed pitches that align with their deep tech focus can significantly increase the chances of securing funding.
Blindspot Ventures is a seed-focused venture capital firm based in Boston, specializing in backing visionary founders who are reshaping industries through platform technologies and infrastructure innovation. The firm is known for partnering with bold, iconoclastic entrepreneurs who challenge the status quo and develop foundational technologies that drive industry evolution. Their portfolio includes cutting-edge companies like Form Energy, Mori, bloXroute, and Volta Labs, all of which are pioneers in fields ranging from renewable energy storage to advanced material science. Blindspot primarily invests in early-stage companies, with a typical check size of $500K to $3M. Their geographic focus is predominantly on the U.S., leveraging Boston’s rich history of innovation and proximity to top-tier academic institutions. Blindspot actively supports its portfolio companies, often taking board seats and offering strategic advice to foster long-term partnerships. Led by managing partners Ahmed Hentati and Hassan Dayekh, Blindspot is driven by a passion for addressing critical global challenges. Hentati, deeply ingrained in Boston’s startup ecosystem, focuses on identifying and backing groundbreaking founders, while Dayekh manages operations and co-leads the investment committee, bringing extensive experience from his background in banking and growth-stage venture capital.
Bloc Ventures is a specialist deep tech investor founded in 2013 by Bruce Beckloff and David Leftley, both veterans of ARM and Vodafone. The firm focuses on early-stage investments in European deep tech companies, particularly those working in cloud computing, connectivity, data science, and security. They aim to support ambitious entrepreneurs building products with the potential to impact entire industries. Bloc Ventures has a robust portfolio of companies, including Helix Geospace (precision antennas), Mindtrace (AI software), Paytia (cloud-based PCI compliance solutions), Pharrowtech (RF semiconductor technology), and Shield-IoT (IoT security platform). These investments highlight Bloc's commitment to advancing technologies that enable significant industry advancements. The firm recently raised over €23.9 million to fund early-stage deep tech startups in Europe, led by IPGL Limited and supported by industry leaders. This funding will support new portfolio additions and follow-on investments, aligning with Bloc’s strategy to scale companies of global significance. Bloc Ventures is headquartered in London and is recognized for its expert-led funding approach, combining technological, commercialization, and financial expertise to help startups reach their full potential. The team includes professionals with extensive backgrounds in the tech industry, venture capital, and company management, ensuring a hands-on and supportive partnership for their portfolio companies
Blockchain Capital, founded in 2013 and based in San Francisco, is a pioneering venture capital firm focusing exclusively on blockchain technology and the crypto ecosystem. The firm manages multiple funds, with the most recent being Blockchain Capital Fund V, which closed at $300 million. Notable investors in this fund include PayPal and Visa. The firm has invested in over 110 companies and protocols, including prominent industry leaders such as Coinbase, Kraken, Anchorage, and OpenSea, as well as DeFi innovators like Aave, Nexus Mutual, and UMA. Blockchain Capital's investment strategy targets blockchain infrastructure, decentralized finance (DeFi), non-fungible tokens (NFTs), and emerging applications of blockchain technology. The leadership team, led by co-founder and managing partner Bart Stephens, emphasizes leveraging their extensive network, research capabilities, and industry contacts to support and grow their portfolio companies. The team has expanded to 15 members, including the recently promoted partner, Aleks Larsen.
Blossom Capital, founded in 2017 and headquartered in London, has quickly established itself as a leading Series A investor in Europe. Led by Ophelia Brown, Imran Ghory, and Alex Lim, Blossom Capital focuses on high-potential sectors such as fintech, consumer internet, Web3, and enterprise SaaS. Notable investments include Moonpay, Checkout.com, Fat Llama, and Tines, demonstrating their knack for backing innovative startups. Blossom's strategy emphasizes deep, hands-on involvement, limiting investments to 5-6 Series A rounds per year to provide focused support. This approach includes assisting with recruitment, go-to-market strategies, and subsequent fundraising efforts. They prioritize building strong, long-term relationships with founders, often spending months getting to know them before committing to an investment. The firm has a robust track record, with portfolio companies like Checkout.com and Moonpay achieving significant growth and valuations. Blossom's $432 million third fund, raised from prominent US and European investors, underscores their commitment to nurturing Europe's tech ecosystem. For startups seeking to partner with Blossom, the key is demonstrating a clear vision and potential for substantial market impact. They value founders who are not only innovative but also resilient and prepared to scale efficiently. Blossom’s team, known for their rigorous support and strategic insight, is dedicated to propelling their portfolio companies to new heights.
Blue Bear Capital is a venture capital firm that invests in high-growth technology companies across the energy, infrastructure, and climate industries. The firm focuses on the digitization of the traditional energy supply chain, the industrialization of renewable energy, and the development of data-driven grids. Key investment themes include leveraging machine learning, industrial internet, and cloud computing technologies to create smarter, more efficient energy solutions. Blue Bear Capital has a strong team with diverse expertise in energy private equity, technology, and entrepreneurial ventures. Partners like Ernst Theodor Sack, Vaughn Blake, and Carolin Funk lead the firm with extensive backgrounds in energy and technology domains (Blue Bear Capital). The firm's advisory board includes notable figures such as Lord John Browne, who bring additional industry insight and experience. The firm’s portfolio includes companies like First Resonance, which enhances manufacturing software principles, Urbint, an AI-driven safety risk prevention platform, and EnMass Energy, which optimizes waste-to-value supply chains. Other notable investments are Demex, providing climate-linked risk management, and Pani Energy, focusing on industrial AI for water treatment efficiency
Blue Horizon Ventures, founded in 2018 by Roger Lienhard and Michael Kleindl, is a venture capital fund focusing on food technology with a mission to drive sustainability and innovation in the food industry. Their notable investments include Alpha Foods, Love Raw, Veestro, The LiveKindly Co., Clara Foods, and TIPA, which are leading the charge in plant-based and sustainable food solutions. The firm invests primarily in alternative proteins, cultivated food, synthetic biology, and sustainable food system innovations, including smart packaging and food waste reduction. Geographically, Blue Horizon Ventures operates on a global scale, with investments in Europe, North America, and beyond, but maintains a particular focus on European and US markets. Blue Horizon Ventures typically invests in Series A and B rounds, with ticket sizes ranging from EUR 300K to 25M over the lifespan of a company. They aim to take significant minority stakes, often between 10-30%. The fund also co-leads investments and provides substantial follow-on capital to support their portfolio companies' growth. The team is bolstered by seasoned entrepreneurs and industry experts, including Brendan Brazier, a former professional Ironman and co-founder of Vega, who joined as a Venture Partner. Blue Horizon Ventures is committed to fostering innovation by partnering with ambitious and disruptive entrepreneurs who are poised to transform the food system for a sustainable future.
Blue Horizon is a Zurich-based venture capital firm focused on investing in the future of food. Founded in 2016 by Bjoern Witte and Roger Lienhard, the firm has established itself as a leader in the sustainable food sector, managing over $850 million in assets and investing in more than 60 companies globally. The firm primarily targets the alternative protein and food technology industries, with notable investments in companies like Impossible Foods, Mosa Meat, and Planted. These investments reflect Blue Horizon's commitment to pioneering innovations that promote sustainability and environmental responsibility. Mosa Meat, for instance, developed the world’s first lab-grown beef burger, while Planted is a notable player in the vegan meat market. Blue Horizon’s investment strategy emphasizes a full lifecycle approach, supporting companies from seed stage through to significant growth phases. They focus on businesses that offer transformative solutions to global challenges in the food system, such as reducing reliance on traditional meat and dairy production, and promoting plant-based and cultured food alternatives. For startups looking to connect with Blue Horizon, demonstrating a strong alignment with their mission of creating a sustainable food system and showcasing innovative solutions that address significant market opportunities are key to forming a successful partnership.
Blue Ocean Partners, managed by SWEN Capital Partners, is a pioneering venture capital firm dedicated to restoring ocean health through impactful investments. Launched in 2021, Blue Ocean has quickly become the world’s largest ocean-focused venture fund, closing at €170 million in 2023, far exceeding its initial target of €120 million. The fund targets startups that are developing innovative solutions to combat key challenges facing the oceans, including overfishing, pollution, and climate change. The fund’s portfolio includes a diverse range of companies that are driving significant environmental impact. For example, ECOsubsea offers environmentally friendly in-water hull cleaning services that reduce carbon emissions and prevent the spread of invasive species. Another portfolio company, BlueNav, develops hybrid electric propulsion systems that help reduce the carbon footprint of marine transportation. Additionally, Avant is pioneering the production of cultivated seafood, offering a sustainable alternative to traditional fishing practices. Blue Ocean Partners is committed to generating both financial returns and measurable environmental outcomes. The fund’s investments are aligned with global efforts to regenerate marine ecosystems and contribute to the broader movement of sustainable ocean innovation. As a co-founder of the 1000 Ocean Start-ups initiative, Blue Ocean Partners plays a key role in scaling transformative ocean-focused technologies globally, further solidifying its leadership in the ocean impact investing space.
Blue Wire Capital, established in 2013, is a London-based venture capital firm that focuses on early-stage investments, particularly in the pre-seed and seed stages. The firm invests across industries such as business software, environmental services, and educational technology. Notable portfolio companies include Climate X, Five, and Praktika.ai. Geographically, their investments are concentrated in Europe, with a strong presence in London. Blue Wire Capital's strategy emphasizes supporting visionary entrepreneurs addressing global challenges through technology. They typically lead investment rounds, with average check sizes around $5.96 million. They are active, engaging in 2-6 deals annually, and maintain a flexible approach to capital deployment. The team includes Bertie Highmore, Head of Investments, who brings experience from Goldman Sachs and Susquehanna International Group. To approach Blue Wire Capital, startups are advised to demonstrate innovative solutions with significant impact potential. The firm values fast and flexible access to capital, providing not just funding but also strategic support and networking opportunities to foster entrepreneurial success.
bmp Ventures is a seasoned venture capital firm based in Berlin, Germany, with over 25 years of experience in early-stage and growth investments. Since its founding in 1997, bmp Ventures has managed 11 venture capital funds and made more than 250 investments, resulting in over 120 exits and more than 20 IPOs. The firm focuses on investing in innovative and scalable companies across various sectors, including digital solutions, industry & deeptech, media & gaming, life sciences & eHealth, cleantech & planet positive, mobility & automotive, and fintech & legaltech. They typically invest between €350,000 to €3 million in seed and early-stage rounds, with the potential to invest up to €10 million per company through subsequent financing rounds. bmp Ventures is known for being a hands-on investor, providing extensive support to their portfolio companies. This includes strategic advice, networking opportunities, assistance with business model refinement, and guidance on fundraising and exit strategies.
BMW i Ventures is a venture capital firm focused on investing in innovative startups that shape the future of mobility and sustainability. Established in 2011, the firm has made over 50 investments in various sectors including transportation, manufacturing, supply chain, and sustainability. Their investment strategy covers a broad spectrum from seed to growth stages, with a focus on Series A and B rounds. Key portfolio companies include ChargePoint, a leading electric vehicle charging network; Solid Power, which develops solid-state battery technology; and Recogni, which designs power-efficient inference engines for edge-based sensors. Other notable investments include Proterra (electric buses), PureCycle (plastic recycling), and Tekion (automotive retail platform). BMW i Ventures recently announced the creation of a new $300 million fund aimed at early to mid-stage startups operating in sustainability and related sectors. This fund, BMW i Ventures' second, continues their commitment to advancing frontier technologies in the automotive sector while emphasizing environmental responsibility.
Boehringer Ingelheim Venture Fund (BIVF) is a dynamic venture capital arm of Boehringer Ingelheim, investing in groundbreaking biotechnologies and therapeutics. BIVF's notable portfolio includes companies like HepaRegenix, focusing on liver regeneration; Imcheck Therapeutics, developing novel cancer immunotherapies; and Asgard Therapeutics, pioneering gene therapy-mediated cancer treatments. BIVF primarily targets biotech startups in areas such as oncology, regenerative medicine, infectious diseases, and digital health, with a strong emphasis on early-stage investments. They invest globally, with significant activity in Europe, the US, and Asia, aiming to foster innovation that aligns with Boehringer Ingelheim's strategic interests. Their strategy involves taking minority stakes and actively supporting companies through the pre-seed, seed, and series A stages. BIVF typically leads funding rounds, providing crucial support in both capital and expertise. They prefer startups that are exploring novel therapeutic approaches with the potential for significant clinical impact. For startups looking to engage with BIVF, it’s essential to have a groundbreaking technology with strong preclinical or early clinical data. They value strategic alignment with Boehringer Ingelheim’s therapeutic areas and appreciate a collaborative approach from entrepreneurs.
Boğaziçi Ventures, established in 2015 and headquartered in Istanbul, Turkey, is a venture capital firm focusing on early-stage investments in technology-driven sectors. They target industries such as fintech, health tech, retail tech, and gaming, aiming to support innovative startups that can achieve substantial growth and impact. Notable investments by Boğaziçi Ventures include Cerebrum Tech, a company specializing in digital transformation solutions, and Hiwell, an online therapy platform. They have made 59 investments, primarily within Turkey, but also in regions like the United Kingdom and the United States. The firm is led by co-founders Barış Özistek and Burak Balık, who, along with their team, emphasize sustainable development goals in their investment strategies. Boğaziçi Ventures supports its portfolio companies with not only financial backing but also strategic guidance to help them scale effectively.
BOLD (Business Opportunities for L'Oréal Development) is L'Oréal's strategic venture capital fund, established in 2018. Focused on redefining the future of beauty, BOLD invests in startups that are pushing the boundaries of innovation in beauty brands, beauty platforms, tech for beauty, and science for beauty. Notable investments include Digital Village, a metaverse-as-a-service platform; Debut, a biotech company revolutionizing ingredient manufacturing; and Timeline, a Swiss longevity biotech company. These investments highlight BOLD's commitment to integrating cutting-edge technology and sustainable practices into the beauty industry. Geographically, BOLD operates globally, leveraging L'Oréal's extensive network to provide startups with unparalleled access to resources and expertise. Their investment strategy centers on strategic minority stakes in companies that align with L'Oréal's innovation goals, particularly in sustainability and advanced beauty tech. BOLD typically leads investment rounds, offering both capital and mentorship to foster growth. They focus on startups with innovative solutions that meet unmet consumer needs and promote sustainable practices. Entrepreneurs can approach BOLD through their website, where they can pitch their ideas and potentially join BOLD's diverse portfolio. The fund is spearheaded by a team of experts, including Barbara Lavernos, Deputy CEO in charge of Research, Innovation, and Technology, who emphasizes a multidimensional approach to beauty and longevity.
Brabantse Ontwikkelings Maatschappij (BOM), based in Tilburg, Netherlands, is a venture capital firm dedicated to fostering innovation and economic growth in the Brabant region. Since its founding in 1983, BOM has been actively investing in startups and scale-ups across various sectors including renewable energy, high-tech systems, agro-food, life sciences, and med-tech. BOM has built a significant portfolio with notable investments in companies like Sirius Medical Systems, which enhances cancer treatment with precise surgical solutions, and AvL Motion, known for developing a robotic asparagus harvester. Another key investment is in LionVolt, which focuses on developing sustainable 3D solid-state batteries. BOM is recognized as the most active venture capital investor in Dutch startups, highlighting its commitment to driving economic impact and innovation in the region. Their strategic approach includes providing financial support and expertise to startups, ensuring these companies can grow effectively and sustainably. This proactive involvement has led to successful exits and significant contributions to societal transitions such as climate-neutral energy solutions and advancements in health technology. With a focus on creating a robust entrepreneurial ecosystem, BOM continues to support and invest in companies that have the potential to make substantial contributions to the Brabant economy and beyond.
BonVenture is a Munich-based venture capital firm specializing in social impact investments. Founded in 2003, the firm focuses on supporting early-stage startups that aim to address social and environmental challenges. BonVenture's investment strategy is centered around social enterprises in the German-speaking region, emphasizing sectors such as renewable energy, health care, and environmental sustainability. Notable investments include Resourcify, a digital waste management and recycling platform; myo, a communication platform for caregivers; and ChargeX, which develops smart power strips for connecting multiple electric vehicles to a single charging station. Other significant investments include Wegatech Greenergy, a residential solar energy system project developer, and 42 Watt, a company specializing in energy efficiency and environmental consulting. BonVenture actively participates in various funding rounds, providing capital and strategic support to help social enterprises scale their impact. The firm has a track record of successful exits, including Emmy, an e-scooter sharing company, and Everskill, a digital training platform. With a commitment to fostering innovation and sustainability, BonVenture continues to support startups that align with its mission of creating positive social and environmental change. The firm leverages its extensive network and industry expertise to help portfolio companies achieve their growth and impact goals.
Boost VC, founded by Adam Draper and Brayton Williams in 2012, is a venture capital firm based in San Mateo, California, that focuses on early-stage investments in frontier technologies. With over $200 million in assets under management, Boost VC typically invests $500,000 in pre-seed startups, supporting over 300 companies. Their portfolio includes notable companies like Coinbase, Protocol Labs, and Snapcard, and spans deep tech sectors such as crypto, VR, AR, AI, space tech, robotics, and bio/health. Boost VC operates a rigorous accelerator program, providing startups with mentorship, resources, and networking opportunities. The three-month program offers intensive support from the Boost VC team and access to a wide network of industry experts and investors. The firm is known for its strong commitment to fostering innovation and diversity within the tech industry, actively supporting women and underrepresented founders. Adam Draper, a fourth-generation venture capitalist, and Brayton Williams, bring extensive experience and a vision for transformative technology startups. The team includes partners like Maddie Callander and Gus Domel, who offer diverse expertise from private aviation to brain health technology.
Borski Fund is a pioneering venture capital firm based in Amsterdam that focuses on closing the gender gap in venture capital by investing in companies led by women or gender-diverse teams. Founded in 2019 by Simone Brummelhuis and Laura Rooseboom, Borski Fund is named after Johanna Borski, a 19th-century Dutch financier who was instrumental in funding the Dutch Central Bank. The fund is dedicated to supporting female entrepreneurs and teams with at least one female executive with equity stakes, aiming to foster innovation, inclusivity, and economic growth. Borski Fund’s investment thesis is centered around the belief that diversity leads to better decision-making and stronger business outcomes. The fund’s portfolio includes companies across various sectors, including technology and sustainability, with a particular focus on those driven by data and AI. Borski Fund also stands out due to its collaboration with major partners like the Visa Foundation, which recently contributed to expanding the fund to €40 million. This partnership reflects a shared commitment to promoting gender equality in the startup ecosystem, and the fund has made significant strides in empowering women-led businesses across Europe. By creating opportunities for women and gender-diverse teams, Borski Fund is not only addressing the significant investment gap in venture capital but also championing a more equitable and inclusive business environment.
Bossanova Investimentos, often referred to as Bossanova Invest, is a prominent venture capital firm based in Brazil, specializing in pre-seed stage investments. Founded in 2011 by Pierre Schurmann and later joined by João Kepler, Bossanova has established itself as the most active micro-VC in Latin America. The firm focuses on B2B and B2B2C technology companies that are innovative, digital, and scalable. Bossanova has invested in over 1,200 startups across more than 1,000 companies, making it a significant player in the early-stage investment scene. Their portfolio includes notable exits such as Glovo, Upsie, and Shift. They employ a rigorous selection process and offer extensive support to their portfolio companies to ensure rapid growth and success. The firm's investment strategy revolves around startups that are over 1.5 years old, have found a problem-solution fit, and are already operational and generating revenue. They avoid investments in sectors that exclusively target government, e-commerce, games, or hardware that competes with existing portfolio companies. Bossanova's network includes over 10,000 co-investors, founders, and partner companies, providing a robust ecosystem for startups to thrive. They also offer educational resources through platforms like Clubb.vc, which provides courses and materials on investment, innovation, and business development. In addition to traditional equity investments, Bossanova has introduced an innovative investment model via Cédula de Crédito Bancário (CCB), which allows investors to gain exposure to the startup ecosystem with capital protection and fixed returns. This approach aims to democratize access to venture capital investments, making it accessible to a broader range of investors.
Boundary Capital is a London-based venture capital firm focused on impact investing in early-stage companies that aim to improve lives and deliver strong commercial returns. Their investment strategy centers on technologies in life sciences, engineering, and data science that address critical global challenges such as healthcare, sustainability, and education. By aligning economic success with positive societal impact, Boundary Capital looks for businesses that offer innovative solutions to real-world problems. The firm typically invests in businesses from late seed to Series B stages, targeting returns of 3x within five to seven years. They place a strong emphasis on companies with proven economic potential and intellectual property advantages. Their portfolio includes high-growth companies like Glyconics, which is developing diagnostics for chronic lung diseases, and Echion, which focuses on fast-charging battery technology. Boundary's team combines extensive entrepreneurial and investment expertise. Led by Managing Partner Dan Somers, the firm supports portfolio companies with strategic guidance, leveraging both their financial investment and hands-on operational support.
Bouygues Développement, established in 2009, is the corporate venture capital arm of the Bouygues Group. It focuses on minority investments in startups that align with the group's diverse business sectors, including construction, real estate, media, and telecoms. Bouygues Développement supports Bouygues Construction, Bouygues Immobilier, Colas, TF1, and Bouygues Telecom in their innovative endeavors. Their investment strategy primarily targets Seed and Series A funding rounds, with initial investments ranging from €100,000 to over €1,000,000. Bouygues Développement aims for equity stakes between 5% and 20%, ensuring a strategic partnership and often securing a board seat to foster close collaboration. Bouygues Développement has built a robust portfolio that includes startups such as Construction Venture, Bouygues Immobilier Recherche et Développement, and Bouygues Telecom Initiatives. These investments reflect their commitment to innovation across their core industries. The team is led by Benoît Michard, Director of Bouygues Développement, who joined the group in 2015 and assumed his current role in 2021. The team also includes Maxime Paghent and Charles-Antoine Saltiel, both responsible for participations and bringing extensive experience in corporate law, finance, and strategic investments. Diane Fiocca, an analyst specializing in venture capital, joined in 2023, bringing expertise from her work with deeptech startups. Bouygues Développement's approach emphasizes strong, enduring relationships with entrepreneurs, providing not only financial support but also strategic guidance to drive successful project outcomes.
BoxOne Ventures, established in 2018 and based in Montreal, Canada, is a venture capital firm that focuses on early-stage investments across diverse and impactful sectors. The firm invests in companies with strong technology platforms in areas such as biotechnology, computational biology, AI and data analytics, digital health, fintech, and food technology. BoxOne Ventures has built a robust portfolio featuring notable investments like Juvena Therapeutics, which raised $41M to advance therapeutic solutions. Other significant investments include companies like dfuse, a blockchain development platform, and Odd Burger, a plant-based fast food chain. The firm’s strategy includes backing talented entrepreneurs and innovative technologies that aim to make a positive difference globally. The team at BoxOne Ventures comprises experienced founders and investors who are deeply involved in the development and support of their portfolio companies. This hands-on approach helps startups navigate the challenges of scaling and achieving market success.
New Science Ventures (NSV), founded in 2004, is a venture capital firm that focuses on investments in life sciences and information technology. With offices in New York and London, NSV aims to leverage breakthrough science to create significant value. The firm has a diverse portfolio, investing in companies that utilize fundamental, science-based innovations to address large unmet needs. NSV's notable investments include Ventyx Biosciences, which raised $114 million to advance its pipeline of immunology programs, and Paragraf, a company that mass-produces graphene electronics. Other significant portfolio companies are Phase Four, which develops next-generation electric propulsion solutions for satellites, and NorthSea Therapeutics, which focuses on novel treatments for liver-related diseases. The firm typically invests in early to mid-stage companies and supports them through crucial value inflection points to help them scale. Their investment strategy is grounded in strong intellectual property protection and a long-term view.
Bpifrance is a French state-backed investment bank focused on fostering innovation and entrepreneurship. Its venture capital arm covers a wide range of sectors, investing in startups at all stages—seed, early, and late stage, as well as growth. Bpifrance has made significant contributions to sectors like life sciences, digital technology, and green energy, aiming to support French companies in becoming global market leaders. One of its flagship initiatives is the Large Venture fund, which invests in fast-growing, capital-intensive companies, with typical investments starting at €10 million in rounds of €20 million or more. Notable investments include Doctolib, a leader in the European e-health sector, and Devialet, known for its groundbreaking audio technology. Bpifrance’s investment strategy emphasizes economic impact alongside financial returns, enabling it to take more risks compared to traditional private investors. It also prioritizes areas like climate tech and deep technology, where it sees gaps in venture capital attention. The firm operates both domestically and internationally, with €17 billion in assets under its Funds of Funds division, backing numerous European and global venture capital firms. Bpifrance’s dual mission—to generate returns and spur innovation—makes it a vital player in Europe’s venture capital ecosystem.
Break Off Capital is a dynamic investment firm dedicated to expanding human potential through science and technology. Their mission is driven by the "Break Off" phenomenon—a cognitive shift in awareness recognizing the fragility of life and the imperative to protect and advance our world. The firm is committed to solving global challenges by channeling resources into cutting-edge scientific and technological advancements. Notable divisions include Break Off Capital, which focuses on funding groundbreaking scientific projects; Break Off Crowd, a platform for community-driven scientific support; and Break Off Labs, which connects researchers with funders to facilitate pioneering research. The team is led by Ricardo Celaya, who brings a wealth of experience from his background in art, finance, and private equity, and Victor Celaya, who has a strong background in media and innovation. They are supported by a network of corporate and scientific advisers, including Shervin Kamkar from Illumina and Dr. Leslie Dewan, a nuclear engineer and conservation technologist. Break Off Capital invests in early-stage ventures that address significant societal issues, emphasizing collaboration and strategic support to foster innovation and impact. Their approach is to integrate financial backing with expert mentorship, ensuring that startups not only receive funding but also the guidance needed to scale effectively.
Breakthrough Energy Ventures, part of the Breakthrough Energy network founded by Bill Gates, focuses on financing and scaling companies that aim to eliminate greenhouse gas emissions globally. With over $3.5 billion in committed capital, BEV invests in more than 110 cutting-edge companies across various stages, from seed to growth. The firm targets technologies capable of significantly reducing greenhouse gases, aiming for at least half a gigaton reduction annually. Key areas of investment include clean hydrogen, long-duration energy storage, sustainable aviation fuel, direct air capture, and green manufacturing. BEV supports companies like H2Pro, which innovates in green hydrogen production, and Heirloom, focused on cost-effective carbon removal. BEV’s strategy involves more than just funding; it provides comprehensive support, including technical, operational, market, and policy expertise to help companies overcome scaling challenges. This holistic approach ensures that new climate technologies can transition from development to widespread commercial adoption. The team at BEV includes experts like Eric Toone, Technical Lead of the Investment Committee, and Megan Wenrich, Vice President of Development. These professionals bring a wealth of knowledge and experience to guide the firm’s investments and initiatives.
Breega, founded in 2015 and based in Paris, is a dynamic venture capital firm built by founders for founders. They focus on early-stage investments, with a mission to bridge the equity and experience gap in the VC industry. Breega's notable investments include quantum tech startup Alice&Bob, regtech firm Didomi, and French unicorn Exotec. Breega’s industry focus spans various tech sectors, including fintech, quantum technology, regtech, green mobility, and cybersecurity. They have recently launched a €150M Europe Seed III fund to support early-stage tech startups and a $75M Africa Seed I fund to invest in promising African startups. Geographically, Breega is expanding its reach with a strong presence in Europe, particularly France, Spain, and the UK, and is now targeting markets in Africa with new offices in Nigeria and Cape Town. Their investment strategy is hands-on, providing startups with comprehensive support through their "Scaling Squad," a team of experts that assist with operational guidance, talent acquisition, and scaling strategies. Breega aims to invest in companies with the potential for significant social impact alongside commercial success. The team includes key members like Co-founder and COO Maximilien Bacot, and they are known for their collaborative approach and commitment to supporting founders throughout their entrepreneurial journey.
Brightlands Venture Partners is a venture capital firm based in Geleen, Netherlands, with a strong focus on investing in startups and scale-ups that address key societal challenges in sustainability and health. Established in 2014, the firm manages several funds, including Brightlands Agrifood Ventures, BVP Fund IV, Chemelot Ventures, and Limburg Ventures, with a combined capital of approximately €120 million. The firm primarily invests in sectors like renewable chemistry, regenerative medicine, agri-food, and digital technologies, aiming to support companies that contribute to a sustainable and healthier future. Brightlands Venture Partners has a diverse portfolio of over 70 companies, including Qorium, a pioneer in cell-cultured leather, and PL BioScience, a leader in sustainable cell culture media. Their investment strategy is not only about providing capital but also involves active involvement and support in scaling the companies, leveraging their deep sector expertise. The leadership team at Brightlands includes experienced professionals like Casper Bruens, Marcel Kloosterman, and Kim de Boer, who collectively bring decades of experience in venture capital and the life sciences industry. Their approach is characterized by a strong emphasis on impact investing, aligning financial returns with measurable societal impact.
BRP-X is a venture capital firm known for its investments in the high-tech sector, particularly focusing on advanced and innovative technologies. The firm emphasizes supporting early-stage companies that demonstrate strong growth potential and the ability to disrupt traditional markets. BRP-X's notable investments include a wide array of companies across various industries. For instance, they have backed AthenaHealth, a leading cloud provider of electronic medical records and revenue cycle management solutions, and Aveanna Healthcare, a prominent pediatric home healthcare company in North America. Another significant investment is in CentralSquare Technologies, which provides public sector software solutions in the United States and Canada. The firm is also known for its involvement in consumer brands like Canada Goose, a designer and manufacturer of premium outdoor apparel, and Bob's Discount Furniture, a major furniture retailer in the Northeast US. Additionally, BRP-X has invested in Bombardier Recreational Products (BRP), a global leader in powersports vehicles and propulsion systems. BRP-X's investment strategy revolves around leveraging their deep industry expertise and extensive network to support their portfolio companies, helping them scale and achieve significant market impact. For more details on their portfolio and investment approach, you can visit their official website or review their profiles on various investment platforms.
Britbots, established by Dominic Keen in 2016, is a UK-based venture capital firm that specializes in investing in early-stage robotics, artificial intelligence (AI), and automation companies. The firm is recognized for its focus on addressing global productivity challenges through automation technologies, which it sees as critical to counteracting declining labor growth, environmental strain, and energy inefficiencies. Britbots manages several funds, including the British Robotics Seed Fund and the Scale-Up Fund, both of which are structured to take advantage of the UK government's SEIS (Seed Enterprise Investment Scheme) and EIS (Enterprise Investment Scheme) tax incentives. These funds primarily target high-potential startups that are developing cutting-edge robotics and AI technologies, with a strong emphasis on capital-efficient projects that can deliver substantial productivity gains. Notable companies in Britbots' portfolio include Muddy Machines, which develops autonomous robots for agricultural tasks, and RAD Propulsion, which creates advanced propulsion systems for the marine industry. The firm’s investments are characterized by their focus on innovative solutions that combine sophisticated software with accessible, off-the-shelf hardware, making advanced robotics more affordable and scalable. Britbots' investment strategy involves not just capital support but also active mentorship and operational guidance, helping startups navigate technical challenges and scale their innovations. This approach is designed to foster long-term growth and deliver significant returns by backing startups that are poised to become leaders in their fields.
Broadview Ventures, founded in 2008 and headquartered in Boston, Massachusetts, is a venture capital firm focused on investing in early-stage life sciences companies. The firm specializes in cardiovascular and neurovascular diseases, aiming to bridge the translational gap between scientific research and clinical application. Broadview Ventures has a robust portfolio that includes companies such as DecImmune Therapeutics, which develops therapies to mitigate injury post-myocardial infarction, and FineHeart, a French medical device company creating innovative cardiac support technologies. Other notable investments include GI Windows, developing non-surgical approaches for treating chronic diseases, and Adient Medical, focusing on absorbable medical devices. The firm has made 79 investments and achieved several successful exits, including Cardialen, VentriNova, and Renovacor. Broadview's investment strategy leverages their extensive industry expertise and network to support companies from seed through later stages of development. Broadview Ventures is led by a team of experienced professionals dedicated to advancing healthcare through innovative solutions. Their strategic focus and targeted investments aim to address unmet medical needs, ultimately improving patient outcomes and advancing the field of cardiovascular and neurovascular health.
Btomorrow Ventures (BTV) is the corporate venture capital arm of British American Tobacco, established in 2020 and headquartered in London. BTV focuses on building transformative and innovative businesses across sectors such as consumer brands, digital transformation, new technologies, and future sciences, with a strong emphasis on Environmental, Social, and Governance (ESG) criteria. BTV has made notable investments in startups like FlexSea, a UK-based company pioneering sustainable, seaweed-derived bioplastics, and Open Book Extracts, a cannabinoid innovation house in North Carolina. Their portfolio includes diverse companies such as Awake Chocolate in Canada, offering functional caffeinated chocolates, and Hesperos in Florida, known for their Human-on-a-Chip® technology. The firm typically participates in early to growth-stage funding, with an average check size of $1 million. BTV is known for leading investment rounds and has a keen interest in companies that align with their sustainability and innovation goals. They actively collaborate with their portfolio companies through initiatives like Btomorrow Labs, providing strategic support and global distribution channels. Led by Managing Director Juan Palacios, the BTV team operates primarily from London, offering a blend of financial investment and strategic partnerships to accelerate the growth of ambitious founders and their disruptive technologies.
b2venture (formerly btov Partners) is a European venture capital firm specializing in early-stage investments. The firm focuses on digital and industrial technology companies, providing substantial support from a robust network of angel investors. Headquartered in Berlin, with additional offices in Munich and St. Gallen, b2venture leverages the collective expertise of seasoned entrepreneurs and investors to back innovative startups. b2venture's portfolio includes notable companies such as DeepL, SumUp, Raisin, and Volocopter. The firm has a track record of successful investments and exits, including companies like Exosome Diagnostics and BUX. They primarily invest in pre-seed and seed rounds, with ticket sizes ranging from EUR 0.25 million to 3.5 million, and continue to support their portfolio companies through various stages of growth. The firm is known for its strong community of angel investors, who provide not only capital but also mentorship and strategic guidance. This collaborative approach has been instrumental in the growth of many successful startups. For instance, DeepL and SumUp have both benefited significantly from b2venture's early-stage support and extensive network. In summary, b2venture combines financial investment with hands-on support and a vast network of industry experts to help startups achieve their full potential, making it a key player in the European venture capital landscape.
Bullnet Capital is a venture capital firm based in Madrid, Spain, specializing in high-technology startups. Founded in 2001 by Javier Ulecia and Miguel del Cañizo, Bullnet Capital focuses on companies with proprietary, breakthrough technologies resulting from significant scientific or technical efforts. They seek startups that have sustainable competitive advantages and can stand the test of time. The firm primarily invests in sectors such as computer hardware, semiconductors, software, and healthcare devices. Their investment strategy emphasizes a hands-on approach, where they not only provide financial support but also strategic and managerial assistance to help companies navigate through their growth phases. Bullnet typically invests between €500,000 and €2,000,000 in early-stage startups. Notable portfolio companies include Digital Legends, Anafocus, and Oncovision, which have benefited from Bullnet's extensive support in both financial and strategic dimensions. The team is led by experienced professionals such as Javier Ulecia, who has a background in aeronautical engineering and an MBA from HEC Paris, and Miguel del Cañizo, a telecom engineer with advanced studies in nanotechnology and photonics. Bullnet Capital's approach focuses on fostering deep, long-term relationships with its portfolio companies, ensuring they have the necessary resources and guidance to succeed in competitive and rapidly evolving markets.
BVP (Business Venture Partners), based in Dublin, is an investment firm focused on supporting innovative companies with a strong emphasis on sustainability and social impact. Their investment portfolio spans sectors like climate technology, health, mobility, and emerging technologies. Notable investments by BVP include Positive Carbon, a company tackling food waste through high-tech sensors and reporting dashboards used in commercial kitchens. The company has clients like the Dalata Hotel Group and Radisson Blu. Another significant investment is in Buymie, a grocery delivery platform that raised €5.8 million in additional funding to expand its operations. BVP has also invested in UFODrive, an all-digital, all-electric car rental service, highlighting their interest in sustainable mobility solutions. BVP provides tailored financial solutions, including equity and debt investments, supporting companies from seed to growth stages. They are also involved in the Employment Investment Incentive Scheme (EIIS) and offer Green Bonds targeting high-impact investments. Overall, BVP is dedicated to fostering companies that not only aim for financial success but also contribute positively to the environment and society.
Butterfly Ventures, established in 2012, is a leading seed-stage venture capital firm based in Helsinki, Finland, with additional offices in Oulu, Stockholm, Tallinn, and Copenhagen. The firm focuses on deep tech and hardware startups in the Nordics and Baltics. Their investment portfolio includes companies such as Wolt and Supercell, showcasing their commitment to backing transformative technology companies. Butterfly Ventures typically invests in pre-seed, seed, and early-stage rounds, with check sizes ranging from €100,000 to €2 million. They emphasize sustainable and science-based innovations, aligning with the EU's Article 8 and Sustainable Finance Disclosure Regulation (SFDR). Their latest fund, Butterfly Venture Fund IV, raised an initial €47 million, aiming for a total of €100 million to support groundbreaking startups across the region. The team at Butterfly Ventures includes experienced professionals like Juho Risku, co-founder and partner, who has a strong background in digital technologies and entrepreneurship. Other key members include Ville Heikkinen, known for his expertise in VC financing and M&A, and Tanya Horowitz, who brings a wealth of experience from her background in asset management and M&A investment banking in New York. Butterfly Ventures is deeply integrated into the Nordic startup ecosystem, actively seeking companies that have the potential for significant societal, environmental, and economic impact. Startups looking to partner with Butterfly Ventures should focus on innovative solutions that address major global challenges, particularly in deep tech and hardware sectors.